A vaccine trial comes to Vermont, a good revenue report for the state, worries over short-staffed schools, and a new visitor policy at Rutland Regional.
A vaccine trial comes to Vermont, a good revenue report for the state, worries over short-staffed schools, and a new visitor policy at Rutland Regional.